Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.280
-0.010 (-0.44%)
At close: Mar 27, 2026
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 185.24 million as of March 27, 2026. Its market cap has decreased by -68.46% in one year.
Market Cap
185.24M
Enterprise Value
160.26M
Revenue
407.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.28
Market Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 185.24M, an increase of 305.70%. That is a compound annual growth rate of 7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 185.24M | -26.69% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 68.77B |
| Sigma Healthcare | 30.14B |
| Pro Medicus | 12.30B |
| Cochlear | 10.85B |
| Tetratherix | 234.54M |
| Lumos Diagnostics Holdings | 211.39M |
| Orthocell | 210.26M |
| Aroa Biosurgery | 196.92M |